Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Circulation. Cardiovascular Interventions|October 9, 2015
Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent TrialMasahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.Journal of the American College of Cardiology|May 21, 2013
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trialMasahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.Cardiovascular Intervention and Therapeutics|June 28, 2014
Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT)Masato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 3, 2023
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT TrialMasahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.The American Journal of Cardiology|July 21, 2010
Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry)Yoshihisa Nakagawa, Takeshi Kimura, Takeshi Morimoto, et al.International Journal of Cardiology|January 31, 2016
Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trialMasato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.Cardiovascular Intervention and Therapeutics|March 7, 2018
Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studiesHirotoshi Watanabe, Takeshi Morimoto, Hiroki Shiomi, et al.The American Journal of Cardiology|October 3, 2015
Comparison of aortic root anatomy and calcification distribution between Asian and Caucasian patients who underwent transcatheter aortic valve implantationSung-Han Yoon, Yohei Ohno, Motoharu Araki, et al.Heart and Vessels|March 13, 2019
Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3-link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: the BEGIN trialMasahiro Yamawaki, Toshiya Muramatsu, Kazuhiro Ashida, et al.Journal of Cardiology|February 5, 2025
Polymer-free sirolimus- and probucol-eluting stents versus durable polymer-based everolimus-eluting stents for percutaneous coronary revascularization: A prospective multicenter randomized clinical trialAkihiro Ikuta, Junji Yajima, Shinya Okazaki, et al.Pageof 13